Saul Priceman, Ph.D., Associate Professor Department of Hematology & Hematopoietic Cell Transplantation and Associate Director of Translational Sciences & Technologies in the T Cell Therapeutics Research Lab at City of Hope (IMAGE)
Caption
City of Hope’s Saul Priceman, Ph.D., is conducting research on chimeric antigen receptor (CAR)-engineered T cell therapy and has demonstrated in the laboratory and in preclinical models that the investigational cell therapy can work against ovarian cancer. The preclinical study was published in Nature Communications.
Credit
City of Hope
Usage Restrictions
Please do not re-use images
License
Licensed content